Comparative expression of syndecan-1 and Ki-67 in peripheral and desmoplastic ameloblastomas and ameloblastic carcinoma

The aims of the present study were to examine whether the pattern of syndecan‐1 expression correlates with cellular proliferation index in desmoplastic ameloblastomas (DA), peripheral ameloblastomas (PA) and ameloblastic carcinomas (AC), and to compare with that previously reported for solid (SA) an...

Full description

Saved in:
Bibliographic Details
Published in:Pathology international Vol. 59; no. 4; pp. 229 - 233
Main Authors: Bologna-Molina, Ronell, Mosqueda-Taylor, Adalberto, Lopez-Corella, Eduardo, De Almeida, Oslei Paes, Carrasco-Daza, Daniel, Farfán-Morales, José E., Molina-Frechero, Nelly, Damián-Matsumura, Pablo
Format: Journal Article
Language:English
Published: Melbourne, Australia Blackwell Publishing Asia 01-04-2009
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract The aims of the present study were to examine whether the pattern of syndecan‐1 expression correlates with cellular proliferation index in desmoplastic ameloblastomas (DA), peripheral ameloblastomas (PA) and ameloblastic carcinomas (AC), and to compare with that previously reported for solid (SA) and unicystic (UA) variants of ameloblastoma. Immunohistochemistry was performed for syndecan‐1 and Ki‐67 in seven ameloblastomas (four DA and three PA) and three AC. Expression of syndecan‐1 was related to the histological subtype of tumors and, in the case of malignancy, to lower expression levels observed in AC (22.5%) than in PA (47.5%) or DA (77.5%) (P < 0.05). Syndecan‐1 expression correlated inversely with Ki‐67 proliferative index: the expression was lower in both types of ameloblastomas (1.5% in DA and 6.4% in PA) than in AC (41.2%; P < 0.05). The present results suggest that the decrease in syndecan‐1 expression and increase in the Ki‐67 index observed in AC is in accordance with its higher aggressiveness as compared to the rare DA and PA. Interestingly, DA had a lower proliferation index as well as the highest levels of syndecan‐1 expression. These data suggest that DA differ from the other types of intraosseous ameloblastomas but more studies are necessary to better understand the role of this protein as a marker in the biological behavior of the epithelial odontogenic neoplasms.
AbstractList The aims of the present study were to examine whether the pattern of syndecan‐1 expression correlates with cellular proliferation index in desmoplastic ameloblastomas (DA), peripheral ameloblastomas (PA) and ameloblastic carcinomas (AC), and to compare with that previously reported for solid (SA) and unicystic (UA) variants of ameloblastoma. Immunohistochemistry was performed for syndecan‐1 and Ki‐67 in seven ameloblastomas (four DA and three PA) and three AC. Expression of syndecan‐1 was related to the histological subtype of tumors and, in the case of malignancy, to lower expression levels observed in AC (22.5%) than in PA (47.5%) or DA (77.5%) ( P < 0.05). Syndecan‐1 expression correlated inversely with Ki‐67 proliferative index: the expression was lower in both types of ameloblastomas (1.5% in DA and 6.4% in PA) than in AC (41.2%; P < 0.05). The present results suggest that the decrease in syndecan‐1 expression and increase in the Ki‐67 index observed in AC is in accordance with its higher aggressiveness as compared to the rare DA and PA. Interestingly, DA had a lower proliferation index as well as the highest levels of syndecan‐1 expression. These data suggest that DA differ from the other types of intraosseous ameloblastomas but more studies are necessary to better understand the role of this protein as a marker in the biological behavior of the epithelial odontogenic neoplasms.
The aims of the present study were to examine whether the pattern of syndecan-1 expression correlates with cellular proliferation index in desmoplastic ameloblastomas (DA), peripheral ameloblastomas (PA) and ameloblastic carcinomas (AC), and to compare with that previously reported for solid (SA) and unicystic (UA) variants of ameloblastoma. Immunohistochemistry was performed for syndecan-1 and Ki-67 in seven ameloblastomas (four DA and three PA) and three AC. Expression of syndecan-1 was related to the histological subtype of tumors and, in the case of malignancy, to lower expression levels observed in AC (22.5%) than in PA (47.5%) or DA (77.5%) (P < 0.05). Syndecan-1 expression correlated inversely with Ki-67 proliferative index: the expression was lower in both types of ameloblastomas (1.5% in DA and 6.4% in PA) than in AC (41.2%; P < 0.05). The present results suggest that the decrease in syndecan-1 expression and increase in the Ki-67 index observed in AC is in accordance with its higher aggressiveness as compared to the rare DA and PA. Interestingly, DA had a lower proliferation index as well as the highest levels of syndecan-1 expression. These data suggest that DA differ from the other types of intraosseous ameloblastomas but more studies are necessary to better understand the role of this protein as a marker in the biological behavior of the epithelial odontogenic neoplasms.
The aims of the present study were to examine whether the pattern of syndecan-1 expression correlates with cellular proliferation index in desmoplastic ameloblastomas (DA), peripheral ameloblastomas (PA) and ameloblastic carcinomas (AC), and to compare with that previously reported for solid (SA) and unicystic (UA) variants of ameloblastoma. Immunohistochemistry was performed for syndecan-1 and Ki-67 in seven ameloblastomas (four DA and three PA) and three AC. Expression of syndecan-1 was related to the histological subtype of tumors and, in the case of malignancy, to lower expression levels observed in AC (22.5%) than in PA (47.5%) or DA (77.5%) (P &lt; 0.05). Syndecan-1 expression correlated inversely with Ki-67 proliferative index: the expression was lower in both types of ameloblastomas (1.5% in DA and 6.4% in PA) than in AC (41.2%; P &lt; 0.05). The present results suggest that the decrease in syndecan-1 expression and increase in the Ki-67 index observed in AC is in accordance with its higher aggressiveness as compared to the rare DA and PA. Interestingly, DA had a lower proliferation index as well as the highest levels of syndecan-1 expression. These data suggest that DA differ from the other types of intraosseous ameloblastomas but more studies are necessary to better understand the role of this protein as a marker in the biological behavior of the epithelial odontogenic neoplasms.
Author De Almeida, Oslei Paes
Farfán-Morales, José E.
Mosqueda-Taylor, Adalberto
Lopez-Corella, Eduardo
Damián-Matsumura, Pablo
Carrasco-Daza, Daniel
Molina-Frechero, Nelly
Bologna-Molina, Ronell
Author_xml – sequence: 1
  givenname: Ronell
  surname: Bologna-Molina
  fullname: Bologna-Molina, Ronell
  organization: Department of Biological and Health Sciences, Universidad Autónoma Metropolitana
– sequence: 2
  givenname: Adalberto
  surname: Mosqueda-Taylor
  fullname: Mosqueda-Taylor, Adalberto
  organization: Health Care Department, Universidad Autónoma Metropolitana Xochimilco
– sequence: 3
  givenname: Eduardo
  surname: Lopez-Corella
  fullname: Lopez-Corella, Eduardo
  organization: Laboratory of Molecular Pathology, Instituto Nacional de Pediatria
– sequence: 4
  givenname: Oslei Paes
  surname: De Almeida
  fullname: De Almeida, Oslei Paes
  organization: Department of Oral Diagnosis, Oral Pathology Section, School of Dentistry of Piracicaba, UNICAMP. Piracicaba, Sao Paolo State, Brazil and
– sequence: 5
  givenname: Daniel
  surname: Carrasco-Daza
  fullname: Carrasco-Daza, Daniel
  organization: Laboratory of Molecular Pathology, Instituto Nacional de Pediatria
– sequence: 6
  givenname: José E.
  surname: Farfán-Morales
  fullname: Farfán-Morales, José E.
  organization: Laboratory of Molecular Pathology, Instituto Nacional de Pediatria
– sequence: 7
  givenname: Nelly
  surname: Molina-Frechero
  fullname: Molina-Frechero, Nelly
  organization: Health Care Department, Universidad Autónoma Metropolitana Xochimilco
– sequence: 8
  givenname: Pablo
  surname: Damián-Matsumura
  fullname: Damián-Matsumura, Pablo
  organization: Department of Biology of Reproduction, Universidad Autónoma Metropolitana Iztapalapa
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19351365$$D View this record in MEDLINE/PubMed
BookMark eNqNUU1v1DAQtVAR_aB_AeXELcEfcT4OHNBCS9WycKDq0ZrYE-ElsYO9S3f_fZ3dVXuEOdjjee_N2H7n5MR5h4RkjBYsxYdVwcqS5qzhdcEpbQvKhZTF9hU5ewZOUi44zWVZiVNyHuOKUlaLir4hp6wVkolKnpHHhR8nCLC2fzHD7RQwRutd5vss7pxBDS5nGTiT3dq8qjPrsgmDnX5hgGFfNxhHPw0Q11ZnMOLgu_ngR4h7_KWUcA1BW5ewt-R1D0PEy-N-Qe6vvvxcfM3vvl_fLD7d5VqmyDU1UGFZdr2Gmrcc0yJ1unwHRlLTGMFkKvVCCw3cMM5Y24pe0AZq2nUoLsj7Q98p-D8bjGs12qhxGMCh30RV1YzRsmz_SeQ0fSSraSI2B6IOPsaAvZqCHSHsFKNqdket1GyCmk1Qsztq747aJum744xNN6J5ER7tSISPB8KjHXD3343Vj5vlnCV9ftDbuMbtsx7C7_RQUUv1sLxWt027fPicWnwTTw6Yr8Y
CitedBy_id crossref_primary_10_1111_jicd_12282
crossref_primary_10_4103_EGJP_EGJP_10_21
crossref_primary_10_1016_j_anndiagpath_2009_10_007
crossref_primary_10_1111_odi_12733
crossref_primary_10_1089_cbr_2011_1018
crossref_primary_10_1016_j_ajoms_2022_06_010
crossref_primary_10_1016_j_oooo_2013_08_023
crossref_primary_10_3390_ijerph18083899
crossref_primary_10_1097_PAI_0000000000000042
crossref_primary_10_1111_his_12995
crossref_primary_10_1016_j_maxilo_2014_03_005
crossref_primary_10_1186_1746_1596_8_50
crossref_primary_10_1016_j_oooo_2015_05_011
crossref_primary_10_1016_j_prp_2012_09_001
crossref_primary_10_4103_jomfp_JOMFP_289_19
crossref_primary_10_1111_jop_12428
crossref_primary_10_1016_j_tripleo_2011_06_036
crossref_primary_10_1155_2018_7048531
crossref_primary_10_1111_j_1365_2559_2011_03954_x
crossref_primary_10_1111_j_1600_0714_2010_00908_x
crossref_primary_10_1016_j_oooo_2015_09_021
crossref_primary_10_1111_j_1600_0714_2012_01195_x
crossref_primary_10_1016_j_oooo_2018_09_009
crossref_primary_10_1155_2013_604560
crossref_primary_10_1177_014556131409300908
crossref_primary_10_1155_2015_683087
crossref_primary_10_1177_1066896914553663
crossref_primary_10_1007_s12105_010_0173_7
crossref_primary_10_1016_j_ajoms_2021_03_007
crossref_primary_10_1007_s12663_016_0923_5
crossref_primary_10_1007_s12105_014_0582_0
crossref_primary_10_1016_j_oraloncology_2022_106122
crossref_primary_10_1007_s40496_016_0087_x
crossref_primary_10_1016_j_joms_2013_11_029
crossref_primary_10_1016_j_oooo_2014_01_021
crossref_primary_10_1016_j_oooo_2015_11_015
crossref_primary_10_1590_0103_6440201300024
crossref_primary_10_1111_odi_12130
crossref_primary_10_1111_odi_12010
Cites_doi 10.1038/sj.bjc.6690088
10.1111/j.1600-0714.2007.00537.x
10.1016/S1368-8375(00)00111-1
10.1242/dev.119.3.841
10.1016/0964-1955(94)90064-7
10.1002/cncr.20542
10.1083/jcb.106.2.423
10.1016/0012-1606(88)90401-0
10.1016/S1368-8375(00)00064-6
10.1016/0014-4827(92)90194-D
10.1006/excr.1994.1330
10.1177/35.10.2957423
10.1016/0012-1606(89)90110-3
10.4103/0970-9290.35836
10.1111/j.1601-0825.2006.01284.x
10.1083/jcb.108.5.1945
10.1016/j.oraloncology.2007.10.007
10.1016/S0021-9258(18)42715-9
10.1111/j.0904-2512.2004.00178.x
10.1902/jop.1995.66.12.1065
10.1111/j.1600-0714.2006.00412.x
10.1016/S0021-9258(18)80001-1
10.1016/j.ijom.2005.06.020
10.1016/S0021-9258(17)39576-5
10.1002/pros.10209
10.1016/0278-2391(91)90061-P
10.1016/S0901-5027(87)80131-5
10.1016/S0021-9258(20)89510-6
10.1016/0030-4220(84)90207-X
10.1016/j.tripleo.2007.05.026
10.1083/jcb.118.4.961
10.1146/annurev.biochem.68.1.729
ContentType Journal Article
Copyright 2009 The Authors. Journal compilation © 2009 Japanese Society of Pathology
Copyright_xml – notice: 2009 The Authors. Journal compilation © 2009 Japanese Society of Pathology
DBID BSCLL
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QP
7X8
DOI 10.1111/j.1440-1827.2009.02355.x
DatabaseName Istex
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
DatabaseTitleList CrossRef
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1440-1827
EndPage 233
ExternalDocumentID 10_1111_j_1440_1827_2009_02355_x
19351365
PIN2355
ark_67375_WNG_K89NWD27_M
Genre article
Journal Article
Comparative Study
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
123
1OB
1OC
29O
31~
33P
36B
3O-
3SF
3UE
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHTB
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABPEJ
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AHEFC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
GSXLS
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
V8K
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
X7M
XG1
YFH
YUY
ZGI
ZZTAW
~IA
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAMNL
AAYXX
CITATION
7QP
7X8
ID FETCH-LOGICAL-c5555-c0da6e44bfca7292e7295c351bad50d8d315729f3c3ca2d1211993f308a70bbe3
IEDL.DBID 33P
ISSN 1320-5463
IngestDate Fri Aug 16 11:22:12 EDT 2024
Fri Aug 16 09:24:38 EDT 2024
Fri Nov 22 00:40:26 EST 2024
Sat Sep 28 07:45:10 EDT 2024
Sat Aug 24 00:54:06 EDT 2024
Wed Oct 30 09:52:49 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5555-c0da6e44bfca7292e7295c351bad50d8d315729f3c3ca2d1211993f308a70bbe3
Notes ArticleID:PIN2355
ark:/67375/WNG-K89NWD27-M
istex:7853E2DB11ACD06AE9D8F0DB1DCA025C8842B4CD
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 19351365
PQID 20546170
PQPubID 23462
PageCount 5
ParticipantIDs proquest_miscellaneous_67110449
proquest_miscellaneous_20546170
crossref_primary_10_1111_j_1440_1827_2009_02355_x
pubmed_primary_19351365
wiley_primary_10_1111_j_1440_1827_2009_02355_x_PIN2355
istex_primary_ark_67375_WNG_K89NWD27_M
PublicationCentury 2000
PublicationDate April 2009
PublicationDateYYYYMMDD 2009-04-01
PublicationDate_xml – month: 04
  year: 2009
  text: April 2009
PublicationDecade 2000
PublicationPlace Melbourne, Australia
PublicationPlace_xml – name: Melbourne, Australia
– name: Australia
PublicationTitle Pathology international
PublicationTitleAlternate Pathol Int
PublicationYear 2009
Publisher Blackwell Publishing Asia
Publisher_xml – name: Blackwell Publishing Asia
References Thesleff I, Jalkanen M, Vainio S, Bernfield M. Cell surface proteoglycan expression correlates with epithelial-mesenchymal interaction during tooth morphogenesis. Dev Biol 1988; 129: 565-72.
Philipsen HP, Reichart PA, Takata T. Desmoplastic ameloblastoma (including 'hybrid' lesion of ameloblastoma). Biological profile based in 100 cases from the literature and own files. Oral Oncol 2001; 37: 455-60.
David G, Bai XM, Van der Schueren B, Marynen P, Cassiman JJ, Van den Berghe H. Spatial and temporal changes in the expression of fibroglycan (syndecan-2) during mouse embryonic development. Development 1993; 119: 841-54.
Koda J, Rapraeger A, Bernfield M. Heparan sulfate proteoglycans from mouse mammary epithelial cells. Cell surface proteoglycan as a receptor for interstitial collagens. J Biol Chem 1985; 260: 4870-77.
Inki P, Larjava H, Haapasalmi K, Miettinen HM, Grenman R, Jalkanen M. Expression of syndecan-1 is induced by differentiation and suppressed by malignant transformation of human keratinocytes. Eur J Cell Biol 1994; 63: 43-51.
Vainio S, Jalkanen M, Thesleff I. Syndecan and tenascin expression is induced by epithelial-mesenchymal interactions in embryonic tooth mesenchyme. J Cell Biol 1989; 108: 1945-54.
Lin SC, Lieu CM, Hahn LJ, Kwan HW. Peripheral ameloblastoma with metastasis. Int J Oral Maxillofac Surg 1987; 16: 202-6.
Sivapathasundharam B, Einstein A, Syed Rafiuddeen I. Desmoplastic ameloblastoma in Indians. Report of five cases and review of the literature. Indian J Dent Res 2007; 18: 218-21.
Sanderson RD, Hinkes MT, Bernfield M. Syndecan-1, a cell surface proteoglycan, changes in size and abundance when keratinocytes stratify. J Invest Dermatol 1992; 66: 314-23.
Slootweg PJ, Müller H. Malignant ameloblastoma or ameloblastic carcinoma. Oral Surg Oral Med Oral Pathol 1984; 57: 168-79.
Salmavirta M, Rauvala H, Elenius K, Jalkanen M. Neurite growth-promoting protein (amphoterin, p30) binds syndecan. Exp Cell Res 1992; 200: 444-51.
Tulumori V, Thomas GA, Fraser IS. The relationship of proliferating cell density at the invasive tumor front with prognostic and risk factors in human oral squamous cell carcinoma. J Oral Pathol Med 2004; 33: 204-8.
Bernfield M, Götte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 1999; 68: 729-77.
Joensuu H, Anttonen A, Eriksson M et al. Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer. Cancer Res 2002; 62: 5210-17.
Zellweger T, Nink C, Mirlacher M et al. Tissue microarray analysis reveals prognostic significance of syndecan-1 expression in prostate cancer. Prostate 2003; 55: 20-29.
Gurol M, Burkes EJ Jr. Peripheral ameloblastoma. J Periodontol 1995; 66: 1065-8.
El-Mofty SK, Gerard NO, Farsi SE, Rodu B. Peripheral ameloblastoma: A clinical and histologic study of 11 cases. J Oral Maxillofac Surg 1991; 49: 970-76.
Kim J, Yook JI. Immunohistochemical study on proliferating cell nuclear antigen expression in ameloblastomas. Eur J Cancer B Oral Oncol 1994; 30B: 126-31.
Elenius K, Määttä A, Salmavirta M, Jalkanen M. Growth factors induce 3T3 cells to express bFGF-binding. J Biol Chem 1992; 25: 6435-41.
Salmavirta M, Elenius K, Vainio S et al. Syndecan from embryonic tooth mesenquime binds tenascin. J Biol Chem 1991; 266: 7733-39.
Saunders S, Bernfield M. Cell surface proteoglycan binds mouse mammary epithelial cells to fibronectin and behaves as a receptor on interstitial matrix. J Cell Biol 1988; 106: 423-30.
Barnes L, Eveson JW, Reichart P, Sidransky D (eds) World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours. Lyon: IARC Press, 2005.
Philipsen HP, Reichart P, Nikai H, Takata T, Kudo Y. Peripheral ameloblastoma: Biological profile based on 160 cases from the literature. Oral Oncol 2001; 37: 17-27.
Vainio S, Lehtonen E, Jalkanen M, Bernfield M, Saxen L. Epithelial-mesenchymal interactions regulate the stage-specific expression of a cell surface proteoglycan, syndecan, in the developing kidney. Dev Biol 1989; 134: 382-91.
Kurokawa H, Zhang M, Matsumoto S, Yamashita Y, Tanaka T, Takamori K. Reduced syndecan-1 expression is correlated with the histological grade of malignancy at the deep invasive front in oral squamous carcinoma. J Oral Pathol Med 2006; 35: 301-6.
Shah L, Walter K, Borczuk A, Kawut S, Sonett J, Gorestein L. Expression of syndecan-1 and expression of epidermal growth factor receptor are associated with survival in patients with non small cell lung carcinoma. Cancer 2004; 101: 1632-8.
Anttonen A, Kajanti M, Heikkila P, Jalkanen M, Joensuu H. Syndecan-1 expression has prognostic significance in head and neck carcinoma. Br J Cancer 1999; 79: 558-64.
Ruoshanti E. Proteoglycans in cell regulation. J Biol Chem 1989; 264: 13369-72.
Benlyazid A, Lacroix-Triki M, Aziza R, Gomez-Brouchet A, Guichard M, Sarini J. Ameloblastic carcinoma of the maxilla: Case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 104: e17-24.
Ledesma C, Mosqueda-Taylor A, Carlos-Bregni R et al. Ameloblastomas: A regional Latin-American multicentric study. Oral Dis 2007; 13: 303-7.
Hayashi K, Hayashi M, Jalkanen M, Firestone JH, Trelstad RL, Bernfield M. Immunocytochemistry of cell surface heparan sulfate proteoglycan in mouse tissue. A light and electron microscopic study. J Histochem Cytochem 1987; 35: 1079-88.
Leocata P, Villari D, Fazzari C, Lentini M, Fortunato C, Nicotina PA. Syndecan-1 and Wingless-type protein-1 in human ameloblastomas. J Oral Pathol Med 2007; 36: 394-9.
Ro Y, Muramatsu T, Shima K et al. Correlation between reduction of syndecan-1 expression and clinico-pathological parameters in squamous cell carcinoma of tongue. Int J Oral Maxillofac Surg 2006; 35: 252-7.
Salmavirta M, Mali M, Heino H, Hermonen J, Jalkanen M. A novel laminin-binding form of syndecan-1 (cell surface proteoglycan) produced by syndecan-1 cDNA-transfected NIH-3T3 cells. Exp Cell Res 1994; 215: 180-88.
David G, Van der Schueren B, Marynen P, Cassiman JJ, Van den Berghe H. Molecular cloning of amphiglycan, a novel integral membrane heparan sulfate proteoglycan expressed by epithelial and fibroblastic cells. J Cell Biol 1992; 118: 961-69.
Bologna-Molina R, Mosqueda-Taylor A, Lopez-Corella E et al. Syndecan-1 (CD138) and Ki-67 expression in different subtypes of ameloblastomas. Oral Oncol 2008; 44: 805-11.
2004; 101
1987; 35
2007; 18
2007; 104
1994; 215
1989; 134
2006; 35
1992; 200
1999; 68
2005
1985; 260
2007; 13
1994; 63
1988; 129
1988; 106
2007; 36
2003; 55
1987; 16
2004; 33
1991; 49
1991; 266
1989; 108
1993; 119
2002; 62
1989; 264
1995; 66
1984; 57
1999; 79
1992; 118
2001; 37
2008; 44
1992; 25
1994; 30B
1992; 66
e_1_2_5_26_2
Elenius K (e_1_2_5_27_2) 1992; 25
e_1_2_5_25_2
e_1_2_5_22_2
e_1_2_5_23_2
e_1_2_5_20_2
Sanderson RD (e_1_2_5_9_2) 1992; 66
e_1_2_5_28_2
e_1_2_5_29_2
e_1_2_5_14_2
e_1_2_5_37_2
e_1_2_5_13_2
Inki P (e_1_2_5_10_2) 1994; 63
e_1_2_5_16_2
e_1_2_5_35_2
e_1_2_5_15_2
Salmavirta M (e_1_2_5_24_2) 1991; 266
e_1_2_5_36_2
e_1_2_5_7_2
e_1_2_5_33_2
e_1_2_5_6_2
e_1_2_5_34_2
e_1_2_5_5_2
e_1_2_5_31_2
e_1_2_5_4_2
e_1_2_5_11_2
e_1_2_5_32_2
e_1_2_5_3_2
Ruoshanti E (e_1_2_5_8_2) 1989; 264
e_1_2_5_18_2
e_1_2_5_17_2
e_1_2_5_19_2
Joensuu H (e_1_2_5_12_2) 2002; 62
e_1_2_5_30_2
Barnes L (e_1_2_5_2_2) 2005
Koda J (e_1_2_5_21_2) 1985; 260
References_xml – volume: 44
  start-page: 805
  year: 2008
  end-page: 11
  article-title: Syndecan‐1 (CD138) and Ki‐67 expression in different subtypes of ameloblastomas
  publication-title: Oral Oncol
– volume: 30B
  start-page: 126
  year: 1994
  end-page: 31
  article-title: Immunohistochemical study on proliferating cell nuclear antigen expression in ameloblastomas
  publication-title: Eur J Cancer B Oral Oncol
– volume: 62
  start-page: 5210
  year: 2002
  end-page: 17
  article-title: Soluble syndecan‐1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer
  publication-title: Cancer Res
– year: 2005
– volume: 215
  start-page: 180
  year: 1994
  end-page: 88
  article-title: A novel laminin‐binding form of syndecan‐1 (cell surface proteoglycan) produced by syndecan‐1 cDNA‐transfected NIH‐3T3 cells
  publication-title: Exp Cell Res
– volume: 200
  start-page: 444
  year: 1992
  end-page: 51
  article-title: Neurite growth‐promoting protein (amphoterin, p30) binds syndecan
  publication-title: Exp Cell Res
– volume: 119
  start-page: 841
  year: 1993
  end-page: 54
  article-title: Spatial and temporal changes in the expression of fibroglycan (syndecan‐2) during mouse embryonic development
  publication-title: Development
– volume: 101
  start-page: 1632
  year: 2004
  end-page: 8
  article-title: Expression of syndecan‐1 and expression of epidermal growth factor receptor are associated with survival in patients with non small cell lung carcinoma
  publication-title: Cancer
– volume: 37
  start-page: 17
  year: 2001
  end-page: 27
  article-title: Peripheral ameloblastoma: Biological profile based on 160 cases from the literature
  publication-title: Oral Oncol
– volume: 129
  start-page: 565
  year: 1988
  end-page: 72
  article-title: Cell surface proteoglycan expression correlates with epithelial‐mesenchymal interaction during tooth morphogenesis
  publication-title: Dev Biol
– volume: 36
  start-page: 394
  year: 2007
  end-page: 9
  article-title: Syndecan‐1 and Wingless‐type protein‐1 in human ameloblastomas
  publication-title: J Oral Pathol Med
– volume: 55
  start-page: 20
  year: 2003
  end-page: 29
  article-title: Tissue microarray analysis reveals prognostic significance of syndecan‐1 expression in prostate cancer
  publication-title: Prostate
– volume: 35
  start-page: 301
  year: 2006
  end-page: 6
  article-title: Reduced syndecan‐1 expression is correlated with the histological grade of malignancy at the deep invasive front in oral squamous carcinoma
  publication-title: J Oral Pathol Med
– volume: 260
  start-page: 4870
  year: 1985
  end-page: 77
  article-title: Heparan sulfate proteoglycans from mouse mammary epithelial cells. Cell surface proteoglycan as a receptor for interstitial collagens
  publication-title: J Biol Chem
– volume: 63
  start-page: 43
  year: 1994
  end-page: 51
  article-title: Expression of syndecan‐1 is induced by differentiation and suppressed by malignant transformation of human keratinocytes
  publication-title: Eur J Cell Biol
– volume: 33
  start-page: 204
  year: 2004
  end-page: 8
  article-title: The relationship of proliferating cell density at the invasive tumor front with prognostic and risk factors in human oral squamous cell carcinoma
  publication-title: J Oral Pathol Med
– volume: 13
  start-page: 303
  year: 2007
  end-page: 7
  article-title: Ameloblastomas: A regional Latin‐American multicentric study
  publication-title: Oral Dis
– volume: 66
  start-page: 314
  year: 1992
  end-page: 23
  article-title: Syndecan‐1, a cell surface proteoglycan, changes in size and abundance when keratinocytes stratify
  publication-title: J Invest Dermatol
– volume: 118
  start-page: 961
  year: 1992
  end-page: 69
  article-title: Molecular cloning of amphiglycan, a novel integral membrane heparan sulfate proteoglycan expressed by epithelial and fibroblastic cells
  publication-title: J Cell Biol
– volume: 16
  start-page: 202
  year: 1987
  end-page: 6
  article-title: Peripheral ameloblastoma with metastasis
  publication-title: Int J Oral Maxillofac Surg
– volume: 108
  start-page: 1945
  year: 1989
  end-page: 54
  article-title: Syndecan and tenascin expression is induced by epithelial‐mesenchymal interactions in embryonic tooth mesenchyme
  publication-title: J Cell Biol
– volume: 37
  start-page: 455
  year: 2001
  end-page: 60
  article-title: Desmoplastic ameloblastoma (including ‘hybrid’ lesion of ameloblastoma). Biological profile based in 100 cases from the literature and own files
  publication-title: Oral Oncol
– volume: 18
  start-page: 218
  year: 2007
  end-page: 21
  article-title: Desmoplastic ameloblastoma in Indians. Report of five cases and review of the literature
  publication-title: Indian J Dent Res
– volume: 106
  start-page: 423
  year: 1988
  end-page: 30
  article-title: Cell surface proteoglycan binds mouse mammary epithelial cells to fibronectin and behaves as a receptor on interstitial matrix
  publication-title: J Cell Biol
– volume: 266
  start-page: 7733
  year: 1991
  end-page: 39
  article-title: Syndecan from embryonic tooth mesenquime binds tenascin
  publication-title: J Biol Chem
– volume: 68
  start-page: 729
  year: 1999
  end-page: 77
  article-title: Functions of cell surface heparan sulfate proteoglycans
  publication-title: Annu Rev Biochem
– volume: 35
  start-page: 252
  year: 2006
  end-page: 7
  article-title: Correlation between reduction of syndecan‐1 expression and clinico‐pathological parameters in squamous cell carcinoma of tongue
  publication-title: Int J Oral Maxillofac Surg
– volume: 25
  start-page: 6435
  year: 1992
  end-page: 41
  article-title: Growth factors induce 3T3 cells to express bFGF‐binding
  publication-title: J Biol Chem
– volume: 79
  start-page: 558
  year: 1999
  end-page: 64
  article-title: Syndecan‐1 expression has prognostic significance in head and neck carcinoma
  publication-title: Br J Cancer
– volume: 35
  start-page: 1079
  year: 1987
  end-page: 88
  article-title: Immunocytochemistry of cell surface heparan sulfate proteoglycan in mouse tissue. A light and electron microscopic study
  publication-title: J Histochem Cytochem
– volume: 264
  start-page: 13369
  year: 1989
  end-page: 72
  article-title: Proteoglycans in cell regulation
  publication-title: J Biol Chem
– volume: 66
  start-page: 1065
  year: 1995
  end-page: 8
  article-title: Peripheral ameloblastoma
  publication-title: J Periodontol
– volume: 57
  start-page: 168
  year: 1984
  end-page: 79
  article-title: Malignant ameloblastoma or ameloblastic carcinoma
  publication-title: Oral Surg Oral Med Oral Pathol
– volume: 104
  start-page: e17
  year: 2007
  end-page: 24
  article-title: Ameloblastic carcinoma of the maxilla: Case report and review of the literature
  publication-title: Oral Surg Oral Med Oral Pathol Oral Radiol Endod
– volume: 49
  start-page: 970
  year: 1991
  end-page: 76
  article-title: Peripheral ameloblastoma: A clinical and histologic study of 11 cases
  publication-title: J Oral Maxillofac Surg
– volume: 134
  start-page: 382
  year: 1989
  end-page: 91
  article-title: Epithelial‐mesenchymal interactions regulate the stage‐specific expression of a cell surface proteoglycan, syndecan, in the developing kidney
  publication-title: Dev Biol
– volume-title: World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours
  year: 2005
  ident: e_1_2_5_2_2
  contributor:
    fullname: Barnes L
– ident: e_1_2_5_11_2
  doi: 10.1038/sj.bjc.6690088
– ident: e_1_2_5_34_2
  doi: 10.1111/j.1600-0714.2007.00537.x
– ident: e_1_2_5_18_2
  doi: 10.1016/S1368-8375(00)00111-1
– volume: 63
  start-page: 43
  year: 1994
  ident: e_1_2_5_10_2
  article-title: Expression of syndecan‐1 is induced by differentiation and suppressed by malignant transformation of human keratinocytes
  publication-title: Eur J Cell Biol
  contributor:
    fullname: Inki P
– ident: e_1_2_5_33_2
  doi: 10.1242/dev.119.3.841
– ident: e_1_2_5_37_2
  doi: 10.1016/0964-1955(94)90064-7
– ident: e_1_2_5_14_2
  doi: 10.1002/cncr.20542
– ident: e_1_2_5_23_2
  doi: 10.1083/jcb.106.2.423
– ident: e_1_2_5_29_2
  doi: 10.1016/0012-1606(88)90401-0
– ident: e_1_2_5_7_2
  doi: 10.1016/S1368-8375(00)00064-6
– volume: 62
  start-page: 5210
  year: 2002
  ident: e_1_2_5_12_2
  article-title: Soluble syndecan‐1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer
  publication-title: Cancer Res
  contributor:
    fullname: Joensuu H
– ident: e_1_2_5_25_2
  doi: 10.1016/0014-4827(92)90194-D
– volume: 66
  start-page: 314
  year: 1992
  ident: e_1_2_5_9_2
  article-title: Syndecan‐1, a cell surface proteoglycan, changes in size and abundance when keratinocytes stratify
  publication-title: J Invest Dermatol
  contributor:
    fullname: Sanderson RD
– ident: e_1_2_5_26_2
  doi: 10.1006/excr.1994.1330
– ident: e_1_2_5_28_2
  doi: 10.1177/35.10.2957423
– ident: e_1_2_5_30_2
  doi: 10.1016/0012-1606(89)90110-3
– ident: e_1_2_5_5_2
  doi: 10.4103/0970-9290.35836
– ident: e_1_2_5_3_2
  doi: 10.1111/j.1601-0825.2006.01284.x
– ident: e_1_2_5_31_2
  doi: 10.1083/jcb.108.5.1945
– ident: e_1_2_5_4_2
  doi: 10.1016/j.oraloncology.2007.10.007
– volume: 25
  start-page: 6435
  year: 1992
  ident: e_1_2_5_27_2
  article-title: Growth factors induce 3T3 cells to express bFGF‐binding
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(18)42715-9
  contributor:
    fullname: Elenius K
– ident: e_1_2_5_36_2
  doi: 10.1111/j.0904-2512.2004.00178.x
– ident: e_1_2_5_16_2
  doi: 10.1902/jop.1995.66.12.1065
– ident: e_1_2_5_15_2
  doi: 10.1111/j.1600-0714.2006.00412.x
– volume: 264
  start-page: 13369
  year: 1989
  ident: e_1_2_5_8_2
  article-title: Proteoglycans in cell regulation
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(18)80001-1
  contributor:
    fullname: Ruoshanti E
– ident: e_1_2_5_35_2
  doi: 10.1016/j.ijom.2005.06.020
– volume: 260
  start-page: 4870
  year: 1985
  ident: e_1_2_5_21_2
  article-title: Heparan sulfate proteoglycans from mouse mammary epithelial cells. Cell surface proteoglycan as a receptor for interstitial collagens
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(17)39576-5
  contributor:
    fullname: Koda J
– ident: e_1_2_5_13_2
  doi: 10.1002/pros.10209
– ident: e_1_2_5_17_2
  doi: 10.1016/0278-2391(91)90061-P
– ident: e_1_2_5_6_2
  doi: 10.1016/S0901-5027(87)80131-5
– volume: 266
  start-page: 7733
  year: 1991
  ident: e_1_2_5_24_2
  article-title: Syndecan from embryonic tooth mesenquime binds tenascin
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(20)89510-6
  contributor:
    fullname: Salmavirta M
– ident: e_1_2_5_19_2
  doi: 10.1016/0030-4220(84)90207-X
– ident: e_1_2_5_20_2
  doi: 10.1016/j.tripleo.2007.05.026
– ident: e_1_2_5_32_2
  doi: 10.1083/jcb.118.4.961
– ident: e_1_2_5_22_2
  doi: 10.1146/annurev.biochem.68.1.729
SSID ssj0017360
Score 2.1278427
Snippet The aims of the present study were to examine whether the pattern of syndecan‐1 expression correlates with cellular proliferation index in desmoplastic...
The aims of the present study were to examine whether the pattern of syndecan-1 expression correlates with cellular proliferation index in desmoplastic...
SourceID proquest
crossref
pubmed
wiley
istex
SourceType Aggregation Database
Index Database
Publisher
StartPage 229
SubjectTerms ameloblastic carcinoma
Ameloblastoma - metabolism
Ameloblastoma - pathology
Carcinoma - metabolism
Carcinoma - pathology
CD138
Cell Proliferation
desmoplastic ameloblastoma
Humans
Immunohistochemistry
Jaw Neoplasms - metabolism
Jaw Neoplasms - pathology
Ki-67
Ki-67 Antigen - biosynthesis
peripheral ameloblastoma
Prognosis
syndecan-1
Syndecan-1 - biosynthesis
Title Comparative expression of syndecan-1 and Ki-67 in peripheral and desmoplastic ameloblastomas and ameloblastic carcinoma
URI https://api.istex.fr/ark:/67375/WNG-K89NWD27-M/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1440-1827.2009.02355.x
https://www.ncbi.nlm.nih.gov/pubmed/19351365
https://search.proquest.com/docview/20546170
https://search.proquest.com/docview/67110449
Volume 59
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwEB61i1T1UqAPCNDWh4pbULK2Y-dYLa8W7WqlFsEt8isSAhLEdqWVuPAT-I38ko6dZLdbUamqmkPkeGIn8cx4xhn7M8AniTZQmlzFjMsyZszoWCvOYkZlqbhEAxFwZo-_idG53D_wMDlfu7UwDT7E_Ieb14zQX3sFV3rym5KHuGRftLCTfbSde96fxEFDWM1Bx_OAgqCLBcMeAX55Us-TFS1ZqhXf6LOn3NBlrzaYpcPV__lBa_CqdU7J50aa1uGZq17Di2Ebfn8Dd4MFVjhxs3YObUXqknjkA4dserx_SImqLDm5wGQmyEVFPJhyQC-4ChTrJtf1DXrt-BSirt1Vrf2Fn6gU6IsspBu_11GFtLdwenjwfXAct7s3xIbjEZvEqswxpkuj0IPvOzxxQ3mqleWJlZamHLNKaqhRfRug5nJa0kQqkWjt6DvoVXXlNoFwbS1zNi8zi6M3YXKJvQo6dlwox01KI0g7ThU3DUhH8evghmEaW9VvuZkXoVWLWQS7gaXzAur20k9yE7w4Gx0VJzIfne1jmWEEHzueF6h6Pp6iKldPJ1gdSlIqkj_fkQn0rhjLI9hohGXxejm2BM14BFmQib9-72L8ZeRTW_9acBtedhGxJN2B3o_bqXsPzyd2-iGozE_TDxPz
link.rule.ids 315,782,786,1408,27933,27934,46064,46488
linkProvider Wiley-Blackwell
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NTtwwEB5RkFouLaUF0pbiQ9VbqmRtx84R8dNFy0ZIpaI3y7EdCQEJYllpJS59BJ6RJ2Hsze52EUgVIofI8cSOY894xh77M8A3iTpQmlzHjMsqZsyUcak5ixmVleYSFUTAme3-EsUfubvnYXJ6k70wY3yI6YSbl4zQX3sB9xPSD6Q8OCY7osWd7KDy_IEG5RLLkC_9fg56NHUpCDrbMuwx4OeX9Tya05yuWvLVPnrMEJ23a4Ni2n_3or-0Am9b-5RsjxnqPSy4ehVe91sP_Ae42ZnBhRM3apfR1qSpiAc_cNhSd39vU6JrS3qnGMwEOa2Jx1MOAAbngWLd4KK5RMMdv0L0hTtvSv_g1yoF-iwK6cYfd1Qj7SP83t873unG7QEOseF4xSaxOnOMlZXRaMR3HN64oTwtteWJlZamHKMqaqjRHRvQ5nJa0URqkZSlo2uwWDe12wDCS2uZs3mVWRzACZNL7FjQtuNCO25SGkE6aSp1OcbpUP-ObxiGsVb9qZu5CrWqRhF8D206TaCvzvw6N8HVSfFT9WRenOximn4EW5NGVyh93qWia9cMB5gdslIqkqffyAQaWIzlEayPuWVWvBxrgmY8giwwxX-XWx0dFD706bkJt-BN97h_qA4Pit5nWJ44yJL0CyxeXw3dJrwa2OHXID_3Rm4YGw
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dTtswFD4aICFu9gss7AdfTLvLlNR27FxOlA5WiCptE7uzHNuRKiCpKJUqccMj7Bn3JDt203admIQQuYgcn9hxbB-fzznOZ4APEm2gNLmOGZdVzJgp41JzFjMqK80lGojAM3v0TRQ_ZffQ0-R8nf8LM-OHWHxw85oRxmuv4CNb_aPkwS_ZES3tZAdt5yfEkxsMUbnn0ad0sPAoCLr8Y9hTwK-u6rkzpxVTteFrfXoXDl2FtcEu9Z495hs9h6ctOiWfZ93pBTxx9UvYPG3976_g5mBJFk7ctF1EW5OmIp76wGE7_b79lRJdW9IfYjATZFgTz6Yc6AsugsS68WUzQtiOTyH60l00pb_wK5WCfBmFcuM3O6pRtg0_eoffD47idvuG2HA8YpNYnTnGyspohPAdhyduKE9LbXlipaUpx6iKGmp0xwauuZxWNJFaJGXp6A6s103tXgPhpbXM2bzKLE7fhMklDiuI7LjQjpuURpDOW0qNZiwd6u_ZDcMw1qrfczNXoVbVNIKPoUkXCfTVuV_lJrg6K76ovsyLsy6mOY1gf97mCnXPO1R07ZrJGLPDnpSK5P93ZALhFWN5BLuzzrIsXo41QTMeQRb6xL3LrQbHhQ_tPTThPmwOuj11clz038DW3DuWpG9h_fpq4t7B2thO3gft-QO7bxbB
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparative+expression+of+syndecan%E2%80%901+and+Ki%E2%80%9067+in+peripheral+and+desmoplastic+ameloblastomas+and+ameloblastic+carcinoma&rft.jtitle=Pathology+international&rft.au=Bologna%E2%80%90Molina%2C+Ronell&rft.au=Mosqueda%E2%80%90Taylor%2C+Adalberto&rft.au=Lopez%E2%80%90Corella%2C+Eduardo&rft.au=De+Almeida%2C+Oslei+Paes&rft.date=2009-04-01&rft.pub=Blackwell+Publishing+Asia&rft.issn=1320-5463&rft.eissn=1440-1827&rft.volume=59&rft.issue=4&rft.spage=229&rft.epage=233&rft_id=info:doi/10.1111%2Fj.1440-1827.2009.02355.x&rft.externalDBID=10.1111%252Fj.1440-1827.2009.02355.x&rft.externalDocID=PIN2355
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1320-5463&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1320-5463&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1320-5463&client=summon